Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-06

Clinical Trial Update: Propranolol for the Treatment of Kaposi Sarcoma in Adults [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating propranolol for the treatment of Kaposi sarcoma in adults, sponsored by Washington University School of Medicine, and is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Propranolol (propranolol)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Kaposi Sarcoma | Phase 2 | Status: RECRUITING